Antibiotics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 – 2030

CHAPTER 1. Industry Overview of Antibiotics Market

1.1. Definition and Scope

1.1.1. Definition of Antibiotics

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Antibiotics Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Antibiotics Market By Product Type

1.2.3. Antibiotics Market By Drug Origin

1.2.4. Antibiotics Market By Route of Administration

1.2.5. Antibiotics Market By Spectrum

1.2.6. Antibiotics Market By Distribution Channel

1.2.7. Antibiotics Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Antibiotics Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Antibiotics Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2021

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021

4.2. R&D Status of Major Manufacturers in 2021

CHAPTER 5. Antibiotics Market By Product Type

5.1. Introduction

5.2. Antibiotics Revenue By Product Type

5.2.1. Antibiotics Revenue (USD Billion) and Forecast, By Product Type, 2018-2030

5.2.2. Penicillin

5.2.2.1. Penicillin Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.3. Cephalosporins

5.2.3.1. Cephalosporins Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.4. Fluoroquinolones

5.2.4.1. Fluoroquinolones Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.5. Macrolides

5.2.5.1. Macrolides Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.6. Carbapenems

5.2.6.1. Carbapenems Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.7. Aminoglycosides

5.2.7.1. Aminoglycosides Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.8. Sulfonamides

5.2.8.1. Sulfonamides Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.9. Other Product Types

5.2.9.1. Other Product Types Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 6. Antibiotics Market By Drug Origin

6.1. Introduction

6.2. Antibiotics Revenue By Drug Origin

6.2.1. Antibiotics Revenue (USD Billion) and Forecast, By Drug Origin, 2018-2030

6.2.2. Natural

6.2.2.1. Natural Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.3. Semi-Synthetic

6.2.3.1. Semi-Synthetic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.4. Synthetic

6.2.4.1. Synthetic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 7. Antibiotics Market By Route of Administration

7.1. Introduction

7.2. Antibiotics Revenue By Route of Administration

7.2.1. Antibiotics Revenue (USD Billion) and Forecast, By Route of Administration, 2018-2030

7.2.2. Oral

7.2.2.1. Oral Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.3. Intravenous

7.2.3.1. Intravenous Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.4. Others

7.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 8. Antibiotics Market By Spectrum

8.1. Introduction

8.2. Antibiotics Revenue By Spectrum

8.2.1. Antibiotics Revenue (USD Billion) and Forecast, By Spectrum, 2018-2030

8.2.2. Narrow-Spectrum Antibiotic

8.2.2.1. Narrow-Spectrum Antibiotic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

8.2.3. Broad-spectrum Antibiotic

8.2.3.1. Broad-spectrum Antibiotic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 9. Antibiotics Market By Distribution Channel

9.1. Introduction

9.2. Antibiotics Revenue By Distribution Channel

9.2.1. Antibiotics Revenue (USD Billion) and Forecast, By Distribution Channel, 2018-2030

9.2.2. Hospital Pharmacy

9.2.2.1. Hospital Pharmacy Antibiotic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

9.2.3. Online Pharmacy

9.2.3.1. Online Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

9.2.4. Retail Pharmacy

9.2.4.1. Retail Pharmacy Antibiotic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

9.2.5. Others

9.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 10. North America Antibiotics Market By Country 

10.1. North America Antibiotics Market Overview

10.2. U.S.

10.2.1. U.S. Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

10.2.2. U.S. Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

10.2.3. U.S. Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

10.2.4. U.S. Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

10.2.5. U.S. Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

10.3. Canada

10.3.1. Canada Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

10.3.2. Canada Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

10.3.3. Canada Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

10.3.4. Canada Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

10.3.5. Canada Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

10.4. North America PEST Analysis

CHAPTER 11. Europe Antibiotics Market By Country

11.1. Europe Antibiotics Market Overview

11.2. U.K.

11.2.1. U.K. Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

11.2.2. U.K. Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

11.2.3. U.K. Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

11.2.4. U.K. Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

11.2.5. U.K. Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.3. Germany

11.3.1. Germany Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

11.3.2. Germany Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

11.3.3. Germany Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

11.3.4. Germany Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

11.3.5. Germany Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.4. France

11.4.1. France Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

11.4.2. France Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

11.4.3. France Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

11.4.4. France Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

11.4.5. France Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.5. Spain

11.5.1. Spain Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

11.5.2. Spain Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

11.5.3. Spain Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

11.5.4. Spain Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

11.5.5. Spain Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.6. Rest of Europe

11.6.1. Rest of Europe Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

11.6.2. Rest of Europe Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

11.6.3. Rest of Europe Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

11.6.4. Rest of Europe Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

11.6.5. Rest of Europe Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.7. Europe PEST Analysis

CHAPTER 12. Asia Pacific Antibiotics Market By Country

12.1. Asia Pacific Antibiotics Market Overview

12.2. China

12.2.1. China Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

12.2.2. China Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

12.2.3. China Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

12.2.4. China Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

12.2.5. China Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

12.3. Japan

12.3.1. Japan Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

12.3.2. Japan Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

12.3.3. Japan Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

12.3.4. Japan Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

12.3.5. Japan Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

12.4. India

12.4.1. India Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

12.4.2. India Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

12.4.3. India Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

12.4.4. India Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

12.4.5. India Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

12.5. Australia

12.5.1. Australia Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

12.5.2. Australia Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

12.5.3. Australia Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

12.5.4. Australia Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

12.5.5. Australia Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

12.6. South Korea

12.6.1. South Korea Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

12.6.2. South Korea Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

12.6.3. South Korea Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

12.6.4. South Korea Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

12.6.5. South Korea Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

12.7. Rest of Asia-Pacific

12.7.1. Rest of Asia-Pacific Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

12.7.2. Rest of Asia-Pacific Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

12.7.3. Rest of Asia-Pacific Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

12.7.4. Rest of Asia-Pacific Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

12.7.5. Rest of Asia-Pacific Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

12.8. Asia Pacific PEST Analysis

CHAPTER 13. Latin America Antibiotics Market By Country

13.1. Latin America Antibiotics Market Overview

13.2. Brazil

13.2.1. Brazil Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

13.2.2. Brazil Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

13.2.3. Brazil Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

13.2.4. Brazil Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

13.2.5. Brazil Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

13.3. Mexico

13.3.1. Mexico Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

13.3.2. Mexico Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

13.3.3. Mexico Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

13.3.4. Mexico Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

13.3.5. Mexico Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

13.4. Rest of Latin America

13.4.1. Rest of Latin America Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

13.4.2. Rest of Latin America Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

13.4.3. Rest of Latin America Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

13.4.4. Rest of Latin America Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

13.4.5. Rest of Latin America Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

13.5. Latin America PEST Analysis

CHAPTER 14. Middle East & Africa Antibiotics Market By Country 

14.1. Middle East & Africa Antibiotics Market Overview

14.2. GCC

14.2.1. GCC Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

14.2.2. GCC Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

14.2.3. GCC Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

14.2.4. GCC Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

14.2.5. GCC Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

14.3. South Africa

14.3.1. South Africa Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

14.3.2. South Africa Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

14.3.3. South Africa Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

14.3.4. South Africa Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

14.3.5. South Africa Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

14.4. Rest of Middle East & Africa

14.4.1. Rest of Middle East & Africa Antibiotics Revenue (USD Billion) and Forecast By Product Type, 2018-2030

14.4.2. Rest of Middle East & Africa Antibiotics Revenue (USD Billion) and Forecast By Drug Origin, 2018-2030

14.4.3. Rest of Middle East & Africa Antibiotics Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

14.4.4. Rest of Middle East & Africa Antibiotics Revenue (USD Billion) and Forecast By Spectrum, 2018-2030

14.4.5. Rest of Middle East & Africa Antibiotics Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

14.5. Middle East & Africa PEST Analysis

CHAPTER 15. Player Analysis Of Antibiotics Market

15.1. Antibiotics Market Company Share Analysis

15.2. Competition Matrix

15.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

15.2.2. New Product Launches and Product Enhancements

15.2.3. Mergers And Acquisition In Global Antibiotics Market

15.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 16. Company Profile

16.1. Abbott Laboratories

16.1.1. Company Snapshot

16.1.2. Business Overview

16.1.3. Financial Overview

16.1.3.1. Revenue (USD Billion), 2021

16.1.3.2. Abbott Laboratories 2021 Antibiotics Business Regional Distribution

16.1.4. Product /Service and Specification

16.1.5. Recent Developments & Business Strategy

16.2. Allergan plc

16.3. Basilea Pharmaceutica Ltd.

16.4. Bayer Healthcare AG

16.5. F. Hoffmann-La Roche AG

16.6. GlaxoSmithKline PLC

16.7. Johnson & Johnson Inc.

16.8. Melinta Therapeutics

16.9. Merck & Co., Inc.

16.10. Novartis AG

16.11. Pfizer Inc.

16.12. Sanofi SA

16.13. Tetraphase Pharmaceuticals